1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for YARW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2019. Start Trial.
Date Value
September 16, 2026 203.6%
September 15, 2026 198.2%
September 14, 2026 202.9%
September 11, 2026 206.4%
September 10, 2026 231.8%
September 09, 2026 263.2%
September 08, 2026 259.8%
September 04, 2026 248.4%
September 03, 2026 225.4%
September 02, 2026 232.9%
September 01, 2026 246.2%
August 31, 2026 268.3%
August 28, 2026 302.1%
August 27, 2026 317.2%
August 26, 2026 347.1%
August 25, 2026 332.2%
August 24, 2026 323.5%
August 21, 2026 304.1%
August 20, 2026 318.2%
August 19, 2026 336.6%
August 18, 2026 332.2%
August 17, 2026 322.6%
August 14, 2026 334.9%
August 13, 2026 340.3%
August 12, 2026 340.8%
Date Value
August 11, 2026 351.1%
August 10, 2026 321.1%
August 07, 2026 293.4%
August 06, 2026 308.5%
August 05, 2026 274.9%
August 04, 2026 272.2%
August 03, 2026 240.9%
July 31, 2026 243.0%
July 30, 2026 196.8%
July 29, 2026 -24.27%
July 28, 2026 -30.72%
July 27, 2026 -29.95%
July 24, 2026 -31.98%
July 23, 2026 -36.32%
July 22, 2026 -19.86%
July 21, 2026 -26.22%
July 20, 2026 -30.36%
July 17, 2026 -36.58%
July 16, 2026 -39.09%
July 15, 2026 -41.30%
July 14, 2026 -46.54%
July 13, 2026 -53.67%
July 10, 2026 -53.80%
July 09, 2026 -53.33%
July 08, 2026 -52.88%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 220.8%
Theriva Biologics, Inc. -45.80%
Nkarta, Inc. 47.18%
Unicycive Therapeutics, Inc. 19.80%
OnKure Therapeutics, Inc. 21.52%